Loading insider details...
Latest Form 4 (Jul 10, 2026): Grant/Award of 6,500 MCRB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 10, 2026 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 6,500 | n/a |
| Apr 11, 2025 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 100,000 | n/a |
| Jul 3, 2024 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 64,564 | n/a |
| Apr 8, 2024 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 60,000 | n/a |
| Jun 23, 2023 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 35,000 | n/a |
| Jun 24, 2022 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 35,000 | n/a |
| Jun 24, 2022 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 35,000 | n/a |
| Jun 21, 2021 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 23,000 | n/a |
| Jun 22, 2020 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 30,000 | n/a |